Full name
DANFARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
86.21.Z - General medical practice activities
86.90.C - Nurses and midwives activities
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0 | -0,4 | -0,5 | -39,8 |
EBITDA | 0 | -0,4 | -0,5 | -51,3 |
Short time liabilities | 0,5 | 0,9 | 1,5 | 66,9 |
Equity capital | 0 | -0,3 | -0,9 | -159,2 |
Operating profit (EBIT) | -0 | -0,4 | -0,5 | -51,3 |
Assets | 0,5 | 0,5 | 0,6 | 9,6 |
Net profit (loss) | -0 | -0,4 | -0,5 | -39,8 |
Cash | 0 | 0 | 0 | 1517,6 |
Net income from sale | 0,4 | 0,2 | 0,1 | -37,9 |
Liabilities and provisions for liabilities | 0,5 | 0,9 | 1,5 | 66,9 |
Working assets | 0,2 | 0,2 | 0,3 | 21,6 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -37,9 | 113,9 | 61,4 | -52,5 |
Equity capital to total assets | 9,3 | -62 | -146,7 | -84,7 |
Gross profit margin | -4,4 | -214,3 | -481,9 | -267,6 |
EBITDA Margin | 1,9 | -197,8 | -481,7 | -283,9 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 409 | 1793 | 4815 | 3022 |
Current financial liquidity indicator | 0.4463825821876526 | 0.27459442615509033 | 0.20009557902812958 | -0,1 |
Net dept to EBITDA | 6.3069071769714355 | -1.4810899496078491 | -1.7845549583435059 | -0,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane